← Human Trials & Peer-Reviewed Studies

A comparison of triclosan and stannous fluoride toothpastes for inhibition of plaque regrowth. A crossover study designed to assess carry over.

Plain-language guide to PMID 9083900 (1997): single-blind randomized controlled trial of Triclosan in 12 subjects.

Key Facts

PMID
9083900
Journal
Journal of clinical periodontology
Year
1997
Study type
Randomized Controlled Trial
Authors
Binney A et al. (4 authors)
DOI
10.1111/j.1600-051x.1997.tb00486.x

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Triclosan, published as a randomized controlled trial.

There have been few comparisons of such products for their chemical plaque inhibitory action divorced from the indeterminate variable of toothbrushing.

This study was a randomised, single-blind, cross-over comparison of 4 products, in a 4-day plaque regrowth design, balanced for residual effects and involving 12 healthy dentate subjects.

Who Took Part

The abstract describes 12 subjects taking part.

By PubMed's age tags, the people studied were adults, both men and women.

How the Study Was Run

In design terms this was a randomized, single-blind and crossover study.

The subjects were allocated by chance, so the Triclosan group and the comparison group should start out alike.

In this single-blind Triclosan study one party knew the assignments and the other did not.

Each person switched between Triclosan and the comparison at some point, usually with a gap in between.

What Was Measured

The test agents were a stannous fluoride toothpaste, a triclosan/copolymer toothpaste, a triclosan/zinc citrate toothpaste and water.

On day 5, plaque was scored by index.

The subject headings attached to it are Anti-Infective Agents, Local, Citric Acid, Dental Plaque, Fluorides, Gingivitis, Mouthwashes and Phosphates.

What This Means in Plain Language

The paper is a randomized, single-blind and crossover study of Triclosan in 12 subjects.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 1997 (Journal of clinical periodontology), a journal based in United States.

More context: all human trials.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.